NeoChord
MN - Maple GroveBiotechnology
Focus: NeoChord is a private medical device company focused on transcatheter mitral valve repair, specifically developing the DS1000 artificial chordae delivery system for patients with mitral regurgitation. The company operates as a specialized cardiovascular device manufacturer based in Minnesota.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About NeoChord
AI assessmentNot HiringNo open roles listed right now. Follow NeoChord to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
NeoChord DS1000
Stable
Growth
Lead product in post-market surveillance phase for transcatheter mitral repair, addressing significant unmet need in structural heart disease.
Pipeline & Clinical Trials
Help build intelligence for NeoChord
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.